Pfizer Could Launch US Bevacizumab This Year Despite Patent Thicket

2019
Pfizer recently said it planned to launch biosimilar bevacizumab in the US this year, but several patents stand in the way • Source: Shutterstock

More from Biosimilars

More from Products